Status:
COMPLETED
Determinants of Compliance With Glaucoma Therapy
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
Alcon Research
Conditions:
Open Angle Glaucoma
Eligibility:
All Genders
19+ years
Brief Summary
To determine the association between medical, demographic, socioeconomic, and therapeutic differences on compliance with topical glaucoma therapy using the Travalert device.
Detailed Description
To determine the association between medical, demographic, socioeconomic, and therapeutic differences on compliance with topical glaucoma therapy using the Travalert device. All participants will have...
Eligibility Criteria
Inclusion
- To be eligible to participate in the study, patients had to be (1) 19 years or older; (2) have a diagnosis of open angle glaucoma (OAG) in 1 or both eyes or ocular hypertension; and (3) using a prostaglandin ocular hypotensive medication in 1 or both eyes.
- The protocol excluded patients with uncontrolled IOP control, known contraindications to Travoprost, clinically significant systemic disease that would interfere with the study, participation in any other research study within 30 days, or change in systemic medications that may alter IOP within 30 days before recruitment.
Exclusion
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT00362622
Start Date
October 1 2005
End Date
January 1 2008
Last Update
August 16 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294